Ammari Zaid, Pak Stella C, Ruzieh Mohammed, Dasa Osama, Tiwari Abhinav, Jaume Juan C, Alfonso-Jaume Maria A
Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
Division of Endocrinology, Diabetes and Metabolism, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
Case Rep Endocrinol. 2018 May 9;2018:4606491. doi: 10.1155/2018/4606491. eCollection 2018.
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
接受他克莫司作为免疫抑制方案一部分的患者发生糖尿病酮症酸中毒（DKA）是一种鲜有报道的不良事件。我们报告一例常染色体显性多囊肾病（ADPKD）患者，既往无糖尿病史，肾移植3个月后出现DKA。
